Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
Members of Congress who traded TRVI
No member of Congress has reported a trade in Trevi Therapeutics, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.